Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells
- 1 September 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9184) , 1092-1093
- https://doi.org/10.1016/s0140-6736(99)03113-x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Stem Cell Factor in Combination With Filgrastim After Chemotherapy Improves Peripheral Blood Progenitor Cell Yield and Reduces Apheresis Requirements in Multiple Myeloma Patients: A Randomized, Controlled TrialBlood, 1999
- Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancerBlood, 1996
- Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex VivoNew England Journal of Medicine, 1995